← All Regenerative Medical Technology Group INC filings

Regenerative Medical Technology Group INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OID
RMTG
Regenerative Medical Technology Group INC
10-K: Regenerative Medical Technology Group 2025 Annual Report
Regenerative Medical Technology Group reports 24% revenue growth for 2025 while highlighting significant going concern risks.
OID
RMTG
Regenerative Medical Technology Group INC
10-K: Regenerative Medical Technology Group Reports Increased Revenue and Outlines 2025 Growth Strategy in Annual Filing
Regenerative Medical Technology Group's annual report highlights a 70.44% revenue increase in 2024 and details strategic initiatives for continued expansion in 2025.
OID
RMTG
Regenerative Medical Technology Group INC
10-K: Meso Numismatics Reports 57% Revenue Increase in 2023 Annual Results, Driven by Global Stem Cell Operations
Meso Numismatics, Inc. reports a significant 57% revenue increase in 2023, primarily driven by its Global Stem Cells Group operations, despite a net loss of $9.8 million.